{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:51:12Z","timestamp":1761058272511},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1996,8,1]],"date-time":"1996-08-01T00:00:00Z","timestamp":838857600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[1996,8]]},"DOI":"10.1007\/bf01486738","type":"journal-article","created":{"date-parts":[[2005,4,14]],"date-time":"2005-04-14T06:13:31Z","timestamp":1113459211000},"page":"353-359","source":"Crossref","is-referenced-by-count":24,"title":["Relationship of the dose of intravenous gammaglobulin to the prevention of infections in adults with common variable immunodeficiency"],"prefix":"10.1007","volume":"20","author":[{"given":"Waldemar","family":"Pruzanski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon","family":"Sussman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Dorian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Van","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolores","family":"Ibanez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald","family":"Redelmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"470","volume":"2","author":"Consensus on IVIG","year":"1990","unstructured":"Consensus on IVIG. 1990. Editorial.Lancet.2:470?472.","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"CR2","first-page":"1","volume":"1","author":"M. Eibl","year":"1989","unstructured":"Eibl, M., andR. J. Wedgwood. 1989. Intravenous immunoglobulin: a review.Immunodef. Rev. 1(Suppl. 1): 1?42.","journal-title":"Immunodef. Rev."},{"key":"CR3","doi-asserted-by":"crossref","first-page":"278","DOI":"10.7326\/0003-4819-112-4-278","volume":"112","author":"S. A. Berkman","year":"1990","unstructured":"Berkman, S. A., M. Lee, andR. G. Gale. 1990. Clinical uses of intravenous immunoglobulin.Ann. Intern. Med. 112:278?292.","journal-title":"Ann. Intern. Med."},{"key":"CR4","first-page":"659","volume-title":"Immunodeficiencies","author":"M. M. Eibl","year":"1993","unstructured":"Eibl, M. M., andR. J. Wedgwood. 1993. Intravenous immunoglobulin: A review.In Immunodeficiencies. F. S. Rosen and M. Seligmann, editors. Academic Publishers, Harwood, pp. 659?688."},{"key":"CR5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0090-1229(87)90123-1","volume":"43","author":"E. Bernatowska","year":"1987","unstructured":"Bernatowska, E., K. Madalinski, W. Janowicz, R. Weremowicz, P. Gutkowski, H. M. Wolf, andM. M. Eibl. 1987. Results of a prospective controlled two-dose crossover study with intravenous immunoglobulin and comparison (retrospective) with plasma treatment.Clin. Immunol. Immunopathol. 43:153?162.","journal-title":"Clin. Immunol. Immunopathol."},{"key":"CR6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0090-1229(85)90176-X","volume":"34","author":"R. W. Steele","year":"1985","unstructured":"Steele, R. W., R. A. Augustine, A. S. Tannenbaum, andD. J. Marmer. 1985. Intravenous immune globulin for hypogammaglobulinemia: A comparison of opsonizing capacity in recipient sera.Clin. Immunol. Immunopathol. 34:275?283.","journal-title":"Clin. Immunol. Immunopathol."},{"key":"CR7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0002-9343(84)90320-6","volume":"76","author":"B. Pirofsky","year":"1984","unstructured":"Pirofsky, B. 1984. Intravenous immune globulin therapy in hypogammaglobulinemia. AReview. Am. J. Med. 76:53?60.","journal-title":"A Review. Am. J. Med."},{"key":"CR8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1423-0410.1986.tb02010.x","volume":"51","author":"C. Cunningham-Rundles","year":"1986","unstructured":"Cunningham-Rundles, C. 1986. Treatment of AB deficiencies.Vox Sang. (Suppl. 2)51:63?68.","journal-title":"Vox Sang. (Suppl. 2)"},{"key":"CR9","first-page":"634","volume":"112","author":"S. Mankarious","year":"1988","unstructured":"Mankarious, S., M. Lee, S. Fischer, K. H. Pyun, H. D. Ochs, V. A. Oxelius, andR. J. Wedgwood. 1988. The half-lives of IgG subclasses and specific antibodies in patients with primary immunodeficiency who are receiving intravenously administered immunoglobulin.J. Lab. Clin. Med. 112:634?640.","journal-title":"J. Lab. Clin. Med."},{"key":"CR10","doi-asserted-by":"crossref","unstructured":"Ochs, H. D., S. H.Fisher, R. J.Wedgwood, D. W.Wara, M. J.Cowan, A. J.Ammann, A.Saxon, M. D.Budinger, R. J.Allred, and R. H.Rousell. 1984. Comparison of highdose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency disease.Am. J. Med. pp. 78?82.","DOI":"10.1016\/0002-9343(84)90324-3"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJM199201093260206","volume":"326","author":"J. M. Dwyer","year":"1992","unstructured":"Dwyer, J. M. 1992. Manipulating the immune system with immune globulin.N. Engl. J. Med. 326:107?116.","journal-title":"N. Engl. J. Med."},{"key":"CR12","first-page":"127","volume":"29","author":"E. W. Gelfand","year":"1992","unstructured":"Gelfand, E. W. 1992. Treatment of autoimmune diseases with intravenous gammaglobulin.Sem. Hemat. (Suppl. 2)29:127?133.","journal-title":"Sem. Hemat. (Suppl. 2)"},{"key":"CR13","first-page":"64","volume":"29","author":"S. V. Kaveri","year":"1992","unstructured":"Kaveri, S. V., G. Dietrich, andM. D. Kazatchkine. 1992. Can intravenous immunoglobulin treatment regulate autoimmune responses?Semin. Hematol. (Suppl. 2)29:64?71.","journal-title":"Semin. Hematol. (Suppl. 2)"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1172\/JCI117012","volume":"93","author":"A. Achiron","year":"1994","unstructured":"Achiron, A., R. Margalit, R. Hershkoviz, D. Markovits, T. Reshef, E. Melamed, I. R. Cohen, andO. Lider. 1994. Intravenous immunoglobulin treatment of experimental T cellmediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor? secretion.J. Clin. Invest. 93:600?605.","journal-title":"J. Clin. Invest."},{"key":"CR15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1994.tb00854.x","volume":"139","author":"Y. Abe","year":"1994","unstructured":"Abe, Y., A. Horiuchi, M. Miyake, andS. Kimura. 1994. Anti-cytokine nature of natural human immunoglobulin: One possible mechanism of the clinical effect of intravenous immunoglobulin therapy.Immuno. Rev. 139:5?19.","journal-title":"Immuno. Rev."},{"key":"CR16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-065X.1994.tb00860.x","volume":"139","author":"A. Sundblad","year":"1994","unstructured":"Sundblad, A., M-A. R. Marcos, E. Malanchere, A. Castro, M. Haury, F. Huetz, A. Nobrega, A. Freitas, andA. Cutinho. 1994. Observations on the mode of action of normal immunoglobulin at high doses.Immunol. Rev. 139:125?158.","journal-title":"Immunol. Rev."},{"key":"CR17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1423-0410.1962.tb03240.x","volume":"7","author":"S. Barandun","year":"1962","unstructured":"Barandun, S., P. Kistler, F. Jeunet, andH. Isliker. 1962. Intravenous administration of human gammaglobulin.Vox Sang. 7:157?174.","journal-title":"Vox Sang."},{"key":"CR18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0002-9343(84)90325-5","volume":"76","author":"R. U. Sorensen","year":"1984","unstructured":"Sorensen, R. U., andS. H. Polmar. 1984. Efficacy and safety of high-dose intravenous immune globulin therapy for antibody deficiency syndrome.Am. J. Med. 76:83?90.","journal-title":"Am. J. Med."},{"key":"CR19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0090-1229(84)90200-9","volume":"31","author":"M. M. Eibl","year":"1984","unstructured":"Eibl, M. M., L. Cairns, andF. S. Rosen. 1984. Safety and efficacy of a monomeric, functionally intact intravenous IgG preparation in patients with primary immunodeficiency syndromes.Clin. Immunol. Immunopathol. 31:151?160.","journal-title":"Clin. Immunol. Immunopathol."},{"key":"CR20","first-page":"173","volume":"1","author":"World Health Organization Scientific Group Report","year":"1989","unstructured":"World Health Organization Scientific Group Report. 1989. Primary Immunodeficiency Diseases.Immunodeficiency Rev. 1:173?205.","journal-title":"Immunodeficiency Rev."},{"key":"CR21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0002-9343(84)90322-X","volume":"76","author":"A. Montanaro","year":"1984","unstructured":"Montanaro, A., andB. Pirofsky. 1984. Prolonged interval high-dose intravenous immunoglobulin in patients with primary immunodeficiency states.Am. J. Med. 76:67?72.","journal-title":"Am. J. Med."}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01486738\/fulltext.html","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01486738.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01486738\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01486738","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T21:23:30Z","timestamp":1586208210000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01486738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,8]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1996,8]]}},"alternative-id":["BF01486738"],"URL":"https:\/\/doi.org\/10.1007\/bf01486738","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,8]]}}}